Kiwi Biosciences
Patent-pending enzymes to break down common dietary triggers
Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.
- Website
- fodzyme.com
- City
- Boston
- Country
- United States
- YC batch
- Summer 2021
- Team
- 10 people
- Stage
- Early stage
- AI-native
- No
See it on the Boston mapSource Spot something wrong?
Compiled from public sources with help from automated tools, including AI, so details can be out of date. How we build profiles.
More Health & bio in Boston
WHOOP$10.1bn
Wearable technology. Valued at $10.1bn (March 2026).
Ginkgo BioworksHiring
Our mission is to make biology easier to engineer.
Modern HealthHiring
A mental health benefits platform for employers.
TetraScience
The only R&D data cloud for life sciences
OpenBiome
A nonprofit stool bank enabling access to fecal transplants.
SiPhox HealthHiring
At-Home health monitoring with silicon photonic chips for data centers
Claim this profile
Free and instant: prove you run fodzyme.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Kiwi Biosciences across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Kiwi Biosciences's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
